Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review-Reference-Cited by-同舟云学术

Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review

Published:2011-09-26 Issue:10 Volume:17 Page:1176-1190
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Cholongitas Evangelos,Goulis John,Akriviadis Evangelos,Papatheodoridis Geore V.

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.22354/fullpdf

Reference67 articles.

1. EASL clinical practice guidelines: management of chronic hepatitis B;European Association for the Study of the Liver;J Hepatol,2009

2. Current management of hepatitis B virus infection before and after liver transplantation;Papatheodoridis;Liver Int,2009

3. Indications for therapy in hepatitis B;Degertekin;Hepatology,2009

4. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review;Papatheodoridis;J Hepatol,2010

5. Liver transplantation in European patients with the hepatitis B surface antigen;Samuel;N Engl J Med,1993

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of hepatitis B immunoglobulin mode of administration on treatment experiences of patients after liver transplantation: Results from an online survey;World Journal of Transplantation;2024-09-18

2. Are We Ready to Discontinue Hepatitis B Immunoglobulins to Prevent Hepatitis B and D Recurrence in Liver Transplant Recipients?;Transplantation;2024-06-13

3. Role of B Cells beyond Antibodies in HBV-Induced Oncogenesis: Fulminant Cancer in Common Variable Immunodeficiency—Clinical and Immunotransplant Implications with a Review of the Literature;Diseases;2024-04-23

4. HBV and HCV Infection Prophylaxis in Liver Transplant Recipients;Infectious Diseases;2023-12-20

5. Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study;American Journal of Transplantation;2023-10